Latest News

Latest Features

CommentariesBrexit BZ
0Brexit’s impact on gene and cell therapy, biosimilars

With the reality of Brexit already impacting the UK’s clinical trials environment, Zamas Lam (QPS; DE, USA) discusses the effect this will have on bioanalytical research, and suggests 10 questions to ask when relocating UK-based preclinical and bioanalysis research projects.